Observational Study Protocol: LIVER-R

NCT06252753 · clinicaltrials.gov ↗

RECRUITING

Status

4490

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatobiliary Cancers

Interventions

OTHER: Durvalumab-based combination therapies in observational study setting
OTHER: Durvalumab-based combination therapies in observational study setting

Sponsor

AstraZeneca

Collaborators

[object Object]